During the past decade, Showa University Koto Toyosu Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Showa University Koto Toyosu Hospital" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Bayer" with 2 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 1 trials sponsored and "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Showa University Koto Toyosu Hospital" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "Tokyo Medical and Dental University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Showa University Koto Toyosu Hospital" are "Ulcerative Colitis" (3 trials), "Anemia" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Atrial Fibrillation" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Showa University Koto Toyosu Hospital" in a lesser frequency.

Most popular intervention types in "Showa University Koto Toyosu Hospital" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (3 trials), "Placebo" (3 trials), "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials) and "DS-8201a" (1 trials). Other intervention names were less common.

The vast majority of trials in "Showa University Koto Toyosu Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Showa University Koto Toyosu Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Showa University Koto Toyosu Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Showa University Koto Toyosu Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".